{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-013266","form_type":"8-K","ticker":"NTRB","cik":"0001676047","company_name":"NutriBand Inc.","filed_at":"2025-02-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.405043+00:00","generated_at":"2026-05-26T22:20:29.421701+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Nutriband formalizes exclusive Aversa Fentanyl partnership with Kindeva; potential $80-200M US sales","bullets":["Signed addendum formalizing exclusive development partnership for Aversa Fentanyl with Kindeva Drug Delivery.","Partnership based on shared development costs in exchange for milestone payments.","Aversa Fentanyl combines Nutriband's abuse-deterrent technology with Kindeva's FDA-approved fentanyl patch.","Estimated peak annual US sales potential of $80M to $200M.","AVERSA technology protected by patents in 46 countries including US, Europe, Japan."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-013266","json":"https://secwatch.observer/filing/0001213900-25-013266.json","markdown":"https://secwatch.observer/filing/0001213900-25-013266.md","text":"https://secwatch.observer/filing/0001213900-25-013266.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1676047/000121390025013266/0001213900-25-013266-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1676047/000121390025013266/ea0231002-8k_nutriband.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T22:20:29.421701+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}